Prospective Validation Studies made using InClinico platform
InClinico utilizes massive amounts of data about the targets, diseases, clinical trials, and even scientists involved with the study at the preclinical and clinical stages. We believe that prospective validation is the best way to predict the outcomes of clinical trials
Enabling multi-omics target discovery and deep biology analysis engine to considerably reduce required time from several months to the span of just a few clicks
Find novel lead-like molecules in a week through this automated, machine learning de-novo drug design and scalable engineering platform
Predict clinical trials success rate, recognize the weak points in trial design, while adopting the best practices in the industry
Discover and Prioritize
Generate
Design and predict
Novel Targets
Novel Molecules
Clinical Trials
INTRODUCING FULLY-INTEGRATED DRUG DISCOVERY SOFTWARE SUITE
Data Source
5M OMICs data samples
A full spectrum of transcriptomics, genomics, epigenomics, proteomics, single cell data
generated by the scientific community
generated by the scientific community
30M Publications
Published biomedical research results
3M Grants
Life sciences research grant funding
3.8M Patents
Patents covering the life sciences industry.
342K Clinical Trials
Explore extra knowledge related to the clinical trials design
13K Drugs
Drugs from Phase 1 of clinical trial
till Launched phase
till Launched phase
NEWS
